FBLN5 and carotid atherosclerosis: Our results demonstrate that in patients with carotid atherosclerosis, the expression levels of FBLN5 and anchoring protein in both smooth muscle cells and endothelial cells are reduced, resulting in weak intercellular interactions and increased cell proliferation and migration.